Funding Opportunities in Cancer Research

 

research1  

For assistance with funding, contact: 
Paige Isom, Research Adminstrator,
Funding and Awards
Phone: 314-454-8980
E-mail:  isomp@wudosis.wustl.edu

 

 

FUNDING OPPORTUNITY SEARCH TOOLS 

Siteman Cancer Center — Internal

Barnes-Jewish Foundation
  

Deadline Funding Opportunity Sponsor Amount Description

LOI: July 15, 2015

 

Application: July 31, 2015

INTERNAL: ACS-Institutional Research Grant ACS $30,000 for one year The Washington University ACS-IRG annually awards up to our investigators a maximum of $30,000 for one year (non-renewable). This program provides pilot funding for junior
faculty conducting cancer research projects to obtain preliminary results that will enable them to compete successfully for national research grants. Investigators already receiving support from the NIH, NSF, ACS or other major organizations are not eligible. Applicants are not required to be members of the Cancer Center.
Sept. 15, 2015 INTERNAL: K12 Paul Calabresi Career Development Award for Clinical Oncology WUSM CRTC 75 percent of scholar's salary (Up to $100,00 for min. 2 years); $30,000 per year to support research, travel and tuition The goal of the K12 Paul Calabresi Career Development Award for Clinical Oncology is to train a new generation of highly skilled investigators with specialized expertise who will be well prepared to lead cancer research. The K12 Paul Calabresi program supports the development of senior fellow, postdoctoral scholars, and junior faculty through patient oriented cancer research training, curricula, and mentored projects.
Ongoing Cancer Research Grant Application Gateway for Cancer Research No cap - applicants should apply for the amount they believe is needed to conduct their clinical trial The Gateway funds clinical trials that have the potential to make an impact on today's cancer patients. There is no restriction on the type of cancer research that can be submitted to The Gateway for review. We fund studies that target specific cancers, and research that examines the wider-reaching impact of systemic therapies on treatment, and quality of life.